Clinical trial Recruiting at 1 site Interventional Ages 7 and up

Using virtual reality to help children with vestibular deficits

Official title: Validation and Comparison of a Virtual Reality Protocol in Children Without Vestibular Pathology and Children With Chronic Vestibular déficits : Prospective Study ReViCHILD

Run by Assistance Publique - Hôpitaux de Paris · NCT04791748 · Data updated 2026-11-12

This study is testing whether virtual reality can help children with balance problems improve their coordination and overall development.

Quick facts

Study typeInterventional
Ages7 Years and up
SexAll
Enrollment140 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedApril 12, 2021
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedApril 3, 2026
Trial IDNCT04791748 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include minors aged 7 to 17 years with unilateral or bilateral chronic vestibular pathology.

Probably not a fit

Patients with ophthalmological or neurological pathologies that could interfere with task performance may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the use of virtual reality to enhance multisensory integration in children with and without vestibular deficits. By immersing participants in a virtual environment, the study aims to promote visual and proprioceptive compensation for vestibular issues, which are crucial for developing postural control and coordination. The research involves vestibular tests and virtual reality interventions, targeting children aged 7 to 17 years. The goal is to establish a protocol that can improve the quality of life and developmental outcomes for affected children.

Why it matters

Potential benefit: If successful, this approach could significantly improve postural control and quality of life for children with vestibular deficits.

How similar studies have gone: While similar approaches have been successful in adults, this specific application in children with vestibular deficits is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Minors aged 7 to 17 years (inclusive)
* Volunteers adult
* Information and consent of holders of parental authority of minors, minors and of adult subjects

Patients :

* Presence of unilateral or bilateral chronic vestibular pathology
* Minor patients followed in consultation at Necker Hospital in the Pediatric ENT department
* Adult patients followed at adult vestibulometry services (Lariboisière and Pitié Salpêtrière Hospitals)

Controls:

* No history of otological surgery and absence of vestibular pathology
* Patients followed in consultation at Necker Hospital, siblings or adult parents

Exclusion Criteria:

* Presence of an ophthalmological pathology (including refractive errors)
* Presence of neurological pathology including epilepsy or any pathology that can alter mobility and interfere with the performance of tasks

Where it's running

  • Hôpital Necker-Enfants Malades
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Françoise Denoyelle, MD, PhD — Assistance Publique - Hôpitaux de Paris
  • Study coordinator: Françoise Denoyelle, MD, PhD
  • Email: f.denoyelle@aphp.fr
  • Phone: 1 71 39 67 85

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.